Manos, K., Burgess, M., Chong, G., Lee, S., Smith, C., Renwick, W., Kempe, S., Murigneux, V., Chowdhury, R., Blombery, P., Nelson, N., Fancourt, T., Hawking, J., Lin, W., Barraclough, A., Wight, J., Keane, C., Hawkes, E. (2025). Expression of the cancer testis antigen PRAME is associated with response to immune checkpoint inhibitor and rituximab priming in treatment-naïve diffuse large B-cell lymphoma. Blood. https://doi.org/10.1182/blood-2025-3306